Advertisement

Introduction to the Immune System

  • Scott McComb
  • Aude Thiriot
  • Lakshmi Krishnan
  • Felicity Stark
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1061)

Abstract

The immune system in a broad sense is a mechanism that allows a living organism to discriminate between “self” and “non-self.” Examples of immune systems occur in multicellular organisms as simple and ancient as sea sponges. In fact, complex multicellular life would be impossible without the ability to exclude external life from the internal environment. This introduction to the immune system explores the cell types and soluble factors involved in immune reactions, as well as their location in the body during development and maintenance. Additionally, a description of the immunological events during an innate and adaptive immune reaction to an infection is discussed, as well as a brief introduction to autoimmunity and cancer immunity.

Key words

Immune system Immunity Vaccines Adaptive immunity Innate immunity Inflammation 

References

  1. 1.
    Jenner E (1749–1823) The three original publications on vaccination against smallpox. The Harvard Classics. 1909–14. www.bartleby.com/38/4/
  2. 2.
    Cavaillon JM (2011) The historical milestones in the understanding of leukocyte biology initiated by Elie Metchnikoff. J Leukoc Biol 90(3):413–424PubMedCrossRefGoogle Scholar
  3. 3.
    Kantha SS (1991) A centennial review; the 1890 tetanus antitoxin paper of von Behring and Kitasato and the related developments. Keio J Med 40(1):35–39PubMedCrossRefGoogle Scholar
  4. 4.
    Turk JL (1994) Almroth Wright: phagocytosis and opsonization. J R Soc Med 87(10):576–577PubMedGoogle Scholar
  5. 5.
    Dreyer WJ, Bennett JC (1965) The molecular basis of antibody formation: a paradox. Proc Natl Acad Sci U S A 54(3):864–869PubMedCrossRefGoogle Scholar
  6. 6.
    Feola M, Merklin R, Cho S, Brockman SK (1977) The terminal pathway of the lymphatic system of the human heart. Ann Thorac Surg 24(6):531–536PubMedCrossRefGoogle Scholar
  7. 7.
    Medina E (2009) Neutrophil extracellular traps: a strategic tactic to defeat pathogens with potential consequences for the host. J Innate Immun 1(3):176–180PubMedCrossRefGoogle Scholar
  8. 8.
    Paust S, von Andrian UH (2011) Natural killer cell memory. Nat Immunol 12(6):500–508PubMedCrossRefGoogle Scholar
  9. 9.
    Berzins SP, Smyth MJ, Baxter AG (2011) Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol 11(2):131–142PubMedCrossRefGoogle Scholar
  10. 10.
    Bettelli E, Oukka M, Kuchroo VK (2007) TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8(4):345–350PubMedCrossRefGoogle Scholar
  11. 11.
    Murphy K, Travers P, Walport M (2008) Janeway’s Immunobiology, 7th edn. Garland Science, New YorkGoogle Scholar
  12. 12.
    Dillman RO (2011) Cancer immunotherapy. Cancer Biother Radiopharm 26(1):1–64PubMedCrossRefGoogle Scholar
  13. 13.
    Simon JH, Jacobs LD, Campion M et al (1998) Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. Ann Neurol 43(1):79–87PubMedCrossRefGoogle Scholar
  14. 14.
    Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H, Volk HD, Döcke WD (1998) IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 101(4):783–794PubMedCrossRefGoogle Scholar
  15. 15.
    Narula SK, Cutler D, Grint P (1998) Immunomodulation of Crohn’s disease by interleukin-10. Agents Actions Suppl 49:57–65PubMedGoogle Scholar
  16. 16.
    Vistnes M, Christensen G, Omland T (2010) Multiple cytokine biomarkers in heart failure. Expert Rev Mol Diagn 10(2):147–157PubMedCrossRefGoogle Scholar
  17. 17.
    Lacour S, Gautier JC, Pallardy M, Roberts R (2005) Cytokines as potential biomarkers of liver toxicity. Cancer Biomark 1(1):29–39PubMedGoogle Scholar
  18. 18.
    Osterholm MT, Kelly NS, Manske JM, Ballering KS, Leighton TR, Moore KA (2012) The compelling need for game-changing influenza vaccines. An analysis of the influenza vaccine enterprise and recommendations for the future. CIDRAP, University of Minnesota. 2Google Scholar
  19. 19.
    Vidal M, Chan DW, Gerstein M, Mann M, Omenn GS, Tagle D, Sechi S (2012) The human proteome: a scientific opportunity for transforming diagnostics, therapeutics, and healthcare. Clin Proteomics 9(1):6PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  • Scott McComb
    • 1
  • Aude Thiriot
    • 2
  • Lakshmi Krishnan
    • 3
  • Felicity Stark
    • 3
  1. 1.Department of Biochemistry, Microbiology, and ImmunologyUniversity of OttawaOttawaCanada
  2. 2.Microbiology and ImmunobiologyHarvard Medical SchoolBostonUSA
  3. 3.Human Health Therapeutics PortfolioNational Research Council CanadaOttawaCanada

Personalised recommendations